|
|
Volumn 49, Issue 3, 2009, Pages 862-867
|
|
Simultaneous quantification of losartan and active metabolite in human plasma by liquid chromatography-tandem mass spectrometry using irbesartan as internal standard
a
|
|
Author keywords
Deproteination; LC MS MS; Losartan; Losartan acid; Simple extraction
|
|
Indexed keywords
DRUG METABOLITE;
IRBESARTAN;
LOSARTAN;
LOSARTAN ACID;
LOSARTAN POTASSIUM;
UNCLASSIFIED DRUG;
ARTICLE;
BIOEQUIVALENCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG STABILITY;
ELECTROSPRAY;
HUMAN;
HUMAN EXPERIMENT;
LIQUID CHROMATOGRAPHY;
MAXIMUM PLASMA CONCENTRATION;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SINGLE DRUG DOSE;
STANDARD;
TANDEM MASS SPECTROMETRY;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
BIPHENYL COMPOUNDS;
CALIBRATION;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
HUMANS;
INDICATORS AND REAGENTS;
LOSARTAN;
QUALITY CONTROL;
REFERENCE STANDARDS;
REPRODUCIBILITY OF RESULTS;
TANDEM MASS SPECTROMETRY;
TETRAZOLES;
|
|
EID: 61649102842
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jpba.2009.01.007 Document Type: Article |
|
Times cited : (38)
|
|
References (8)
|
